Galaxy Surfactants Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 8 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹7.1K Cr
Galaxy Surfactants aims for a 20%+ EBITDA CAGR over the next five years, indicating strong earnings growth. Galaxy Surfactants targets roughly 20% EBITDA CAGR over the next five years, aiming to nearly 2.5x EBITDA growth.
From Galaxy Surfactants Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Price
₹2,333
Market Cap
₹7.1K Cr
P/E Ratio
25.6
How does Galaxy Surfactants Ltd rank in Chemicals & Petrochemicals?
Compare Galaxy Surfactants Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Galaxy Surfactants Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹1.3K Cr, net profit ₹62 Cr.
Full financials →📊 Revenue & Sales Performance
- →Galaxy Surfactants aims for a 20%+ EBITDA CAGR over the next five years, indicating strong earnings growth.
- →Volume currently at 2.5 lakh tons; future volume targets not explicitly specified but expected to scale significantly with new products and market expansion.
- →Growth driven by entry into beauty and wellness segments with higher-margin specialty products like modern sun care, derma ingredients, anti-aging actives.
- →Focus on premiumization and penetration in developed markets (Americas and Europe) alongside defending and growing the Indian and AMET (Africa-Middle East-Turkey) markets.
- →Organic growth capital allocation of 50%-60% of operating cash flows to fuel expansion.
- →Innovation pipeline of 20+ new products staged over five years.
- →Market expansion includes leveraging TRI-K subsidiary and targeting fast-growing segments such as leave-on skincare.
- →Indian market expected to grow ~8%-10%, AMET volumes stabilized with growth prospects, rest of world growth ~10%-12%.
📈 Profitability & Margins
- →Galaxy Surfactants targets roughly 20% EBITDA CAGR over the next five years, aiming to nearly 2.5x EBITDA growth.
- →EBITDA per ton is expected to increase significantly to around INR 25,000, driven by new high-margin products, especially in beauty and wellness segments.
- →Growth projection is back-ended, resembling an orchestra: initial years leveraging past investments with stronger growth in later years.
- →The company plans to invest 50%-60% of incremental operating cash flows into organic growth, focusing on new geographies (Americas, Europe) and new product categories (beauty & wellness).
- →Operational excellence and innovation in specialty ingredients will be key drivers for sustainable earnings growth.
- →Inorganic growth via strategic alliances and acquisitions will complement organic growth to achieve Vision 2030.
- →ROCE is expected to bounce back to ~22% as new assets contribute meaningfully over five years.
🏗️ Capital Expenditure Plans
- →Galaxy plans to invest 50% to 60% of its incremental operating cash flows into organic growth over the next five years, focusing on beauty and wellness segments.
- →Significant capital will be required to support this growth, as indicated by K. Natarajan and CFO Abhijit Damle.
- →Capital allocation will be balanced across dividends (15%), organic growth (50-60%), and inorganic opportunities like strategic alliances and acquisitions.
- →The company aims to leverage inorganic growth especially through acquisitions, as seen with TRI-K USA acquired in 2009, which now contributes over 20% to earnings.
- →Investment will focus on new geographies (Americas, Europe), advanced specialty ingredients (skin care, anti-aging, sun care actives), and sustainability-driven innovations.
- →Digital transformation including automation and AI integration also represents a strategic area of investment to improve agility and operational excellence.
💰 Fundraising & Capital Structure
- →Galaxy Surfactants plans significant capital investment primarily through organic growth.
- →Around 50% to 60% of incremental operating cash flows will be allocated to fund organic growth opportunities.
- →The remaining capital will cover dividends (around 15%) and inorganic growth/investments.
- →No explicit mention of new fundraising through debt or equity was made in the discussed sections.
- →The company emphasizes disciplined and prudent capital allocation with a strong balance sheet and credit profile.
- →Inorganic growth will be funded from remaining headroom after organic investment and dividends, with strategic alliances and partnerships being possible routes.
- →Overall, the company intends to finance growth through internal accruals rather than raising fresh debt or equity at present.
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Galaxy Surfactants Ltd Q4 FY25 results?
Galaxy Surfactants aims for a 20%+ EBITDA CAGR over the next five years, indicating strong earnings growth. Galaxy Surfactants targets roughly 20% EBITDA CAGR over the next five years, aiming to nearly 2.5x EBITDA growth.
What is Galaxy Surfactants Ltd share price analysis?
Galaxy Surfactants Ltd currently shows a neutral. The stock trades at a P/E of 25.6 with a market cap of ₹7,112 Cr. Investors should review the full earnings analysis for detailed insights.
Is Galaxy Surfactants Ltd planning capital expenditure?
Galaxy plans to invest 50% to 60% of its incremental operating cash flows into organic growth over the next five years, focusing on beauty and wellness segments.
Keep Galaxy Surfactants Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.